Replies to post #129438 on Biotech Values

[palindromy]

We are covering the BIIB call here http://stks.co/nZU

[jbog]

Dew,

You are correct it is not a direct comparision, it would have needed to be much larger if it attempted to compare the two active drugs. It was however a double blind, randomized trial that consisted of one patent trial and four arms. The four arms were placebo, BG (BID), BG (TID), GA and placebo.

BG out impressively outperformed GA when they were both measured against the placebo in all counts so far.

I never mentioned (you must have misread) that BG beat GA in a stat sig fashion, but I did come to the conclusion that BG is a very impressive drug at this point.

[masterlongevity]

Dew, even if the trial was not powered to determine superiority over copaxone, if BG-12 would have "beat copaxone with ease", then it would have been statistically superior. It obviously was not as it was not included in the PR. Too me, this means they are equivalent in my book